nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—Yawning—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0252	CcSEcCtD
Clonazepam—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0187	0.111	CbGeAlD
Clonazepam—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0247	CcSEcCtD
Clonazepam—TSPO—appendage—amyotrophic lateral sclerosis	0.016	0.0955	CbGeAlD
Clonazepam—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0204	CcSEcCtD
Clonazepam—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0193	CcSEcCtD
Clonazepam—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0183	CcSEcCtD
Clonazepam—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0173	CcSEcCtD
Clonazepam—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0171	CcSEcCtD
Clonazepam—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0167	CcSEcCtD
Clonazepam—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0156	CcSEcCtD
Clonazepam—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0155	CcSEcCtD
Clonazepam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0143	CcSEcCtD
Clonazepam—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0142	CcSEcCtD
Clonazepam—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0141	CcSEcCtD
Clonazepam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.0101	0.0599	CbGeAlD
Clonazepam—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.01	0.0135	CcSEcCtD
Clonazepam—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.01	0.0135	CcSEcCtD
Clonazepam—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00929	0.0125	CcSEcCtD
Clonazepam—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00908	0.0122	CcSEcCtD
Clonazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00889	0.0529	CbGeAlD
Clonazepam—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00863	0.0116	CcSEcCtD
Clonazepam—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00828	0.0112	CcSEcCtD
Clonazepam—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00812	0.0109	CcSEcCtD
Clonazepam—Gout—Riluzole—amyotrophic lateral sclerosis	0.00806	0.0109	CcSEcCtD
Clonazepam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00796	0.0107	CcSEcCtD
Clonazepam—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0104	CcSEcCtD
Clonazepam—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00767	0.0103	CcSEcCtD
Clonazepam—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00744	0.01	CcSEcCtD
Clonazepam—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00744	0.01	CcSEcCtD
Clonazepam—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0098	CcSEcCtD
Clonazepam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0098	CcSEcCtD
Clonazepam—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00719	0.00969	CcSEcCtD
Clonazepam—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00692	0.00932	CcSEcCtD
Clonazepam—Coma—Riluzole—amyotrophic lateral sclerosis	0.00688	0.00927	CcSEcCtD
Clonazepam—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0066	0.00889	CcSEcCtD
Clonazepam—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0088	CcSEcCtD
Clonazepam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00647	0.00872	CcSEcCtD
Clonazepam—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00641	0.00863	CcSEcCtD
Clonazepam—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00641	0.00863	CcSEcCtD
Clonazepam—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00794	CcSEcCtD
Clonazepam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00784	CcSEcCtD
Clonazepam—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00784	CcSEcCtD
Clonazepam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00577	0.0344	CbGeAlD
Clonazepam—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00574	0.00774	CcSEcCtD
Clonazepam—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0056	0.00755	CcSEcCtD
Clonazepam—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00736	CcSEcCtD
Clonazepam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00736	CcSEcCtD
Clonazepam—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00731	CcSEcCtD
Clonazepam—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00725	CcSEcCtD
Clonazepam—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00725	CcSEcCtD
Clonazepam—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00719	CcSEcCtD
Clonazepam—TSPO—embryo—amyotrophic lateral sclerosis	0.00532	0.0317	CbGeAlD
Clonazepam—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00711	CcSEcCtD
Clonazepam—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0052	0.007	CcSEcCtD
Clonazepam—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0052	0.007	CcSEcCtD
Clonazepam—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00698	CcSEcCtD
Clonazepam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00514	0.00692	CcSEcCtD
Clonazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00509	0.0303	CbGeAlD
Clonazepam—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00508	0.00685	CcSEcCtD
Clonazepam—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00505	0.0068	CcSEcCtD
Clonazepam—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00673	CcSEcCtD
Clonazepam—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00666	CcSEcCtD
Clonazepam—TSPO—brainstem—amyotrophic lateral sclerosis	0.00488	0.0291	CbGeAlD
Clonazepam—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00652	CcSEcCtD
Clonazepam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00482	0.0065	CcSEcCtD
Clonazepam—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00637	CcSEcCtD
Clonazepam—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00637	CcSEcCtD
Clonazepam—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00637	CcSEcCtD
Clonazepam—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00612	CcSEcCtD
Clonazepam—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00453	0.0061	CcSEcCtD
Clonazepam—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00595	CcSEcCtD
Clonazepam—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00588	CcSEcCtD
Clonazepam—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00586	CcSEcCtD
Clonazepam—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00579	CcSEcCtD
Clonazepam—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00576	CcSEcCtD
Clonazepam—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00571	CcSEcCtD
Clonazepam—Depression—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00566	CcSEcCtD
Clonazepam—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00556	CcSEcCtD
Clonazepam—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00552	CcSEcCtD
Clonazepam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00402	0.024	CbGeAlD
Clonazepam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00402	0.024	CbGeAlD
Clonazepam—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00535	CcSEcCtD
Clonazepam—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00532	CcSEcCtD
Clonazepam—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00512	CcSEcCtD
Clonazepam—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00511	CcSEcCtD
Clonazepam—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00509	CcSEcCtD
Clonazepam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00507	CcSEcCtD
Clonazepam—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00507	CcSEcCtD
Clonazepam—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00506	CcSEcCtD
Clonazepam—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00503	CcSEcCtD
Clonazepam—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00502	CcSEcCtD
Clonazepam—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00501	CcSEcCtD
Clonazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00371	0.0221	CbGeAlD
Clonazepam—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00499	CcSEcCtD
Clonazepam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00359	0.0214	CbGeAlD
Clonazepam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00359	0.0214	CbGeAlD
Clonazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00357	0.0213	CbGeAlD
Clonazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00355	0.0212	CbGeAlD
Clonazepam—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00476	CcSEcCtD
Clonazepam—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00473	CcSEcCtD
Clonazepam—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0046	CcSEcCtD
Clonazepam—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.0034	0.0203	CbGeAlD
Clonazepam—Chills—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00457	CcSEcCtD
Clonazepam—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0045	CcSEcCtD
Clonazepam—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00446	CcSEcCtD
Clonazepam—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00444	CcSEcCtD
Clonazepam—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00437	CcSEcCtD
Clonazepam—Tension—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00435	CcSEcCtD
Clonazepam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00431	CcSEcCtD
Clonazepam—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00429	CcSEcCtD
Clonazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00317	0.0189	CbGeAlD
Clonazepam—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00426	CcSEcCtD
Clonazepam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00416	CcSEcCtD
Clonazepam—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00412	CcSEcCtD
Clonazepam—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0041	CcSEcCtD
Clonazepam—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00303	0.0181	CbGeAlD
Clonazepam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00408	CcSEcCtD
Clonazepam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00302	0.018	CbGeAlD
Clonazepam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00302	0.018	CbGeAlD
Clonazepam—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00405	CcSEcCtD
Clonazepam—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00297	0.004	CcSEcCtD
Clonazepam—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00398	CcSEcCtD
Clonazepam—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00397	CcSEcCtD
Clonazepam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00291	0.0173	CbGeAlD
Clonazepam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00291	0.0173	CbGeAlD
Clonazepam—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00392	CcSEcCtD
Clonazepam—Cough—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00387	CcSEcCtD
Clonazepam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00284	0.0169	CbGeAlD
Clonazepam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00284	0.0169	CbGeAlD
Clonazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00283	0.0169	CbGeAlD
Clonazepam—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00378	CcSEcCtD
Clonazepam—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00378	CcSEcCtD
Clonazepam—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00378	CcSEcCtD
Clonazepam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00376	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00375	CcSEcCtD
Clonazepam—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00373	CcSEcCtD
Clonazepam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00369	CcSEcCtD
Clonazepam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00365	CcSEcCtD
Clonazepam—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00362	CcSEcCtD
Clonazepam—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00362	CcSEcCtD
Clonazepam—Infection—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0036	CcSEcCtD
Clonazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00267	0.0159	CbGeAlD
Clonazepam—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00355	CcSEcCtD
Clonazepam—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00354	CcSEcCtD
Clonazepam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00353	CcSEcCtD
Clonazepam—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00352	CcSEcCtD
Clonazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00257	0.0153	CbGeAlD
Clonazepam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00345	CcSEcCtD
Clonazepam—TSPO—nervous system—amyotrophic lateral sclerosis	0.00256	0.0152	CbGeAlD
Clonazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00251	0.015	CbGeAlD
Clonazepam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00338	CcSEcCtD
Clonazepam—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00246	0.0147	CbGeAlD
Clonazepam—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0033	CcSEcCtD
Clonazepam—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00327	CcSEcCtD
Clonazepam—TSPO—cerebellum—amyotrophic lateral sclerosis	0.00241	0.0143	CbGeAlD
Clonazepam—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00323	CcSEcCtD
Clonazepam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00322	CcSEcCtD
Clonazepam—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00319	CcSEcCtD
Clonazepam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00315	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00312	CcSEcCtD
Clonazepam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00312	CcSEcCtD
Clonazepam—GABRG2—brain—amyotrophic lateral sclerosis	0.00231	0.0138	CbGeAlD
Clonazepam—GABRB2—brain—amyotrophic lateral sclerosis	0.00231	0.0138	CbGeAlD
Clonazepam—Pain—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0031	CcSEcCtD
Clonazepam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0031	CcSEcCtD
Clonazepam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00298	CcSEcCtD
Clonazepam—GABRB2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0022	0.0245	CbGpPWpGaD
Clonazepam—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00296	CcSEcCtD
Clonazepam—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00288	CcSEcCtD
Clonazepam—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00286	CcSEcCtD
Clonazepam—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00286	CcSEcCtD
Clonazepam—GABRA3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0021	0.0234	CbGpPWpGaD
Clonazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.00204	0.0121	CbGeAlD
Clonazepam—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00201	0.0224	CbGpPWpGaD
Clonazepam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00267	CcSEcCtD
Clonazepam—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00197	0.0117	CbGeAlD
Clonazepam—NAT2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00196	0.0218	CbGpPWpGaD
Clonazepam—TSPO—brain—amyotrophic lateral sclerosis	0.00195	0.0116	CbGeAlD
Clonazepam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0026	CcSEcCtD
Clonazepam—ALB—brain—amyotrophic lateral sclerosis	0.00191	0.0114	CbGeAlD
Clonazepam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00256	CcSEcCtD
Clonazepam—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00248	CcSEcCtD
Clonazepam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00239	CcSEcCtD
Clonazepam—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00176	0.0196	CbGpPWpGaD
Clonazepam—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00175	0.0104	CbGeAlD
Clonazepam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0023	CcSEcCtD
Clonazepam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00228	CcSEcCtD
Clonazepam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00228	CcSEcCtD
Clonazepam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00227	CcSEcCtD
Clonazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0016	0.0178	CbGpPWpGaD
Clonazepam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00215	CcSEcCtD
Clonazepam—NAT2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.0015	0.0167	CbGpPWpGaD
Clonazepam—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00148	0.00879	CbGeAlD
Clonazepam—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00847	CbGeAlD
Clonazepam—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00139	0.00828	CbGeAlD
Clonazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00133	0.0148	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00125	0.0139	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00119	0.0132	CbGpPWpGaD
Clonazepam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00119	0.00708	CbGeAlD
Clonazepam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00114	0.00681	CbGeAlD
Clonazepam—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00114	0.0127	CbGpPWpGaD
Clonazepam—CYP2E1—brain—amyotrophic lateral sclerosis	0.00113	0.00672	CbGeAlD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00101	0.0113	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000996	0.0111	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000965	0.0107	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000934	0.0104	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000926	0.0103	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000891	0.00991	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000878	0.00977	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000873	0.00971	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000866	0.00963	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000854	0.0095	CbGpPWpGaD
Clonazepam—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.000852	0.00947	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000825	0.00918	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000809	0.009	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000787	0.00875	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000761	0.00846	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000755	0.00839	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000747	0.00831	CbGpPWpGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000744	0.00827	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000726	0.00807	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000702	0.00781	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000696	0.00774	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.000695	0.00773	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000678	0.00754	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000673	0.00749	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000673	0.00749	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00067	0.00745	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.000662	0.00736	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00066	0.00734	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000647	0.0072	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000642	0.00714	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000626	0.00696	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00062	0.0069	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00062	0.0069	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00062	0.00689	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000616	0.00685	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000608	0.00677	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000596	0.00663	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000592	0.00658	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000583	0.00648	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000577	0.00641	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000577	0.00641	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000572	0.00637	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000567	0.00631	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000562	0.00625	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000562	0.00625	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000562	0.00625	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000561	0.00624	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000556	0.00619	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00055	0.00612	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00055	0.00612	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000542	0.00603	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000538	0.00598	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000538	0.00598	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000533	0.00593	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000527	0.00587	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000527	0.00587	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00052	0.00578	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000514	0.00572	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000513	0.00571	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000496	0.00552	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000496	0.00551	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000492	0.00547	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00049	0.00545	CbGpPWpGaD
Clonazepam—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000489	0.00544	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000487	0.00541	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000475	0.00529	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000475	0.00529	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00047	0.00523	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000466	0.00518	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000461	0.00513	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000461	0.00513	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000453	0.00504	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000442	0.00491	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000442	0.00491	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000435	0.00483	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000434	0.00482	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000434	0.00482	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00043	0.00478	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000421	0.00469	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000421	0.00469	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000416	0.00463	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000415	0.00462	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000414	0.0046	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000411	0.00457	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000404	0.00449	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000404	0.00449	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000396	0.00441	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000394	0.00438	CbGpPWpGaD
Clonazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000381	0.00424	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00038	0.00423	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000376	0.00418	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000369	0.0041	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00036	0.00401	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000353	0.00393	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000353	0.00393	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000353	0.00392	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000347	0.00386	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00034	0.00379	CbGpPWpGaD
Clonazepam—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000325	0.00362	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00032	0.00356	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000315	0.0035	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000308	0.00343	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000302	0.00336	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000291	0.00324	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000288	0.0032	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00028	0.00312	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000279	0.00311	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000279	0.00311	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000277	0.00309	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000275	0.00306	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000266	0.00296	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000255	0.00284	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000252	0.0028	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000252	0.0028	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000238	0.00264	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000238	0.00264	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000234	0.0026	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000229	0.00255	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000227	0.00252	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000227	0.00252	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000223	0.00248	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00022	0.00245	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000217	0.00242	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000217	0.00242	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000214	0.00238	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000212	0.00235	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000202	0.00225	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000198	0.00221	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000194	0.00215	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000193	0.00215	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000191	0.00212	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00019	0.00211	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00019	0.00211	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000186	0.00207	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000184	0.00205	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000184	0.00204	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000176	0.00195	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000169	0.00188	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000159	0.00177	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000151	0.00168	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00015	0.00167	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000148	0.00164	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000145	0.00162	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000143	0.00159	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000143	0.00159	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000143	0.00159	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000142	0.00158	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000138	0.00154	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000134	0.00149	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00013	0.00145	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000128	0.00142	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000123	0.00137	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000123	0.00136	CbGpPWpGaD
Clonazepam—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000123	0.00136	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000121	0.00135	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00012	0.00134	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00012	0.00134	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000115	0.00128	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000114	0.00127	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000114	0.00127	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000114	0.00126	CbGpPWpGaD
Clonazepam—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000112	0.00125	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000109	0.00121	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000109	0.00121	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000106	0.00118	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000104	0.00116	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000103	0.00115	CbGpPWpGaD
Clonazepam—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	9.8e-05	0.00109	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.69e-05	0.00108	CbGpPWpGaD
Clonazepam—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	8.86e-05	0.000986	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.64e-05	0.000961	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.52e-05	0.000948	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	8.18e-05	0.00091	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.82e-05	0.000869	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.78e-05	0.000866	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	7.21e-05	0.000802	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.91e-05	0.000769	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	6.72e-05	0.000747	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.62e-05	0.000736	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.62e-05	0.000736	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.2e-05	0.00069	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	6.2e-05	0.00069	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.05e-05	0.000673	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.92e-05	0.000659	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.65e-05	0.000628	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.63e-05	0.000626	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.34e-05	0.000594	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.29e-05	0.000589	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	5.09e-05	0.000566	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.79e-05	0.000532	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.65e-05	0.000517	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.22e-05	0.000469	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.63e-05	0.000403	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.35e-05	0.000372	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.18e-05	0.000354	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.18e-05	0.000354	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.93e-05	0.000325	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.75e-05	0.000306	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.75e-05	0.000306	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.74e-05	0.000304	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.51e-05	0.00028	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.41e-05	0.000268	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	2.08e-05	0.000231	CbGpPWpGaD
Clonazepam—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	2.07e-05	0.00023	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.65e-05	0.000183	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.48e-05	0.000164	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.000158	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.000151	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000124	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.65e-06	8.51e-05	CbGpPWpGaD
